Alzheimer’s disease affects more than five million Americans. This disease destroys brain cells, resulting in the deterioration of the victims’ intellectual functions and they’re ability to interact with others. Families of patients with Alzheimer’s disease provide most of the care, resulting in emotional distress, strain in family relationships, decrease in immune function and economic losses.
After many years of ups and downs resulting from research endeavors, for the first time in generations, we are able to detect the damage that the disease causes in the brain many years before the symptoms become noticeable. This gives way to a window providing many years to intervene so that patients and families will never have to experience the devastation of Alzheimer’s disease. In addition, for those already suffering from the disease, we are working to develop treatments that would stop or delay the deterioration in intellectual functioning and help the families manage the challenging behaviors often observed in the late stages of the disease.
Our team offers unconditional support to families and patients, acknowledging the difficulties they go through and helping them utilize community services that will decrease the burden of managing this terrible disease. Here at Roper St. Francis, we are proud to be on the cutting edge of this effort, providing South Carolinians with access to the newest treatments available anywhere in the world. We believe that working together with the community, we will be able to see a world without Alzheimer’s disease during our lifetime.
To learn more, please visit www.rsfh.com/alzheimers.
By:Jacobo Mintzer, MD, MBA, director of the Roper St. Francis Clinical Biotechnology Research Institute